Cargando…

LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451

This study examined the effects of long non-coding RNA (lncRNA) BC032020 on the development of human pancreatic ductal adenocarcinoma (PDAC), and the potential molecular mechanisms responsible for these effects. The expression of BC032020 was assessed in 20 pairs of PDAC tumor tissues and adjacent n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhipeng, Chen, Hongxi, Lu, Yebin, Feng, Tiecheng, Sun, Weijia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843399/ https://www.ncbi.nlm.nih.gov/pubmed/29532883 http://dx.doi.org/10.3892/ijo.2018.4289

Ejemplares similares

Downregulation of ULK1 by microRNA‐372 inhibits the survival of human pancreatic adenocarcinoma cells
por: Chen, Hongxi, et al.
Publicado: (2017)

Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma
por: Lu, Si-Yuan, et al.
Publicado: (2022)

LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017)

LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing
por: Chen, Qi Wen, et al.
Publicado: (2023)

The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma
por: Chen, Bo, et al.
Publicado: (2020)

LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
por: Zhang, Yunxiang, et al.
Publicado: (2023)

LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway
por: Xie, Rong, et al.
Publicado: (2023)

Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo
por: Du, Jiang, et al.
Publicado: (2021)

Circulating lncRNA BC030099 Increases in Preeclampsia Patients
por: Sun, Yuhong, et al.
Publicado: (2019)

The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
por: Melendez-Zajgla, Jorge, et al.
Publicado: (2021)

LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma
por: Huang, Shanshan, et al.
Publicado: (2021)

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
por: Yang, Huijie, et al.
Publicado: (2022)

LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway
por: Li, Wei, et al.
Publicado: (2021)

LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis
por: Zhu, Hong-Yan, et al.
Publicado: (2021)

Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma
por: Hao, Sijie, et al.
Publicado: (2018)

lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma
por: Chen, Lei, et al.
Publicado: (2018)

Analysis of lncRNA–mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinoma
por: Qian, Jing, et al.
Publicado: (2019)

Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF-β signaling
por: Lu, Huimin, et al.
Publicado: (2019)

Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
por: Wang, Yuxin, et al.
Publicado: (2022)

Retraction Note: Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo
por: Du, Jiang, et al.
Publicado: (2023)

Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase
por: Cappadocia, Laurent, et al.
Publicado: (2015)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR‐539
por: Nai, Yongjun, et al.
Publicado: (2019)

lncRNA Differentiation Antagonizing Nonprotein Coding RNA Overexpression Accelerates Progression and Indicates Poor Prognosis in Pancreatic Ductal Adenocarcinoma [Retraction]
Publicado: (2023)

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1
por: Huang, Jiayuan, et al.
Publicado: (2020)

Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells
por: Furuta, Tomoaki, et al.
Publicado: (2021)

The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2012)

Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma
por: Li, Kexin, et al.
Publicado: (2023)

Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
por: Furukawa, Daisuke, et al.
Publicado: (2017)

LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?
por: Di Fiore, Riccardo, et al.
Publicado: (2021)

LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA
por: Li, Duan, et al.
Publicado: (2021)

FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
por: Gao, Jian, et al.
Publicado: (2022)

Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma
por: Song, Jukun, et al.
Publicado: (2018)

The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma
por: Liu, Pingping, et al.
Publicado: (2017)

LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway
por: Wu, Liping, et al.
Publicado: (2020)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fq2s2pu4687bfern7iehoicucc